Literature DB >> 19754467

Investigation of the H(+)-myo-inositol transporter (HMIT) as a neuronal regulator of phosphoinositide signalling.

Elena Di Daniel1, James N Kew, Peter R Maycox.   

Abstract

Phosphoinositide signalling regulates a series of important neuronal processes that are thought to be altered in mood disorders. Furthermore, mood-stabilizing drugs inhibit key enzymes that regulate phosphoinositide production and alter neuronal growth cone morphology in an inositol-reversible manner. Inositol is taken up by neurons from the extracellular fluid, presumably via membrane transporters; it can also be synthesized by the enzyme MIP-synthase (myo-inositol-1-phosphate synthase) and, in addition, it is generated by inositol phospholipid hydrolysis. The neuronal-specific HMIT (H(+)-myo-inositol transporter) represents a potential regulator of inositol signalling in neurons that warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19754467     DOI: 10.1042/BST0371139

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  3 in total

Review 1.  Chronic treatment with anti-bipolar drugs causes intracellular alkalinization in astrocytes, altering their functions.

Authors:  Dan Song; Baoman Li; Enzhi Yan; Yi Man; Marina Wolfson; Ye Chen; Liang Peng
Journal:  Neurochem Res       Date:  2012-07-28       Impact factor: 3.996

Review 2.  Phosphoinositides: tiny lipids with giant impact on cell regulation.

Authors:  Tamas Balla
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

Review 3.  Myoinositol in Autoimmune Thyroiditis.

Authors:  Sabrina Rosaria Paparo; Silvia Martina Ferrari; Armando Patrizio; Giusy Elia; Francesca Ragusa; Chiara Botrini; Eugenia Balestri; Fabrizio Guarneri; Salvatore Benvenga; Alessandro Antonelli; Poupak Fallahi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-28       Impact factor: 6.055

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.